<code id='715FF3EFAD'></code><style id='715FF3EFAD'></style>
    • <acronym id='715FF3EFAD'></acronym>
      <center id='715FF3EFAD'><center id='715FF3EFAD'><tfoot id='715FF3EFAD'></tfoot></center><abbr id='715FF3EFAD'><dir id='715FF3EFAD'><tfoot id='715FF3EFAD'></tfoot><noframes id='715FF3EFAD'>

    • <optgroup id='715FF3EFAD'><strike id='715FF3EFAD'><sup id='715FF3EFAD'></sup></strike><code id='715FF3EFAD'></code></optgroup>
        1. <b id='715FF3EFAD'><label id='715FF3EFAD'><select id='715FF3EFAD'><dt id='715FF3EFAD'><span id='715FF3EFAD'></span></dt></select></label></b><u id='715FF3EFAD'></u>
          <i id='715FF3EFAD'><strike id='715FF3EFAD'><tt id='715FF3EFAD'><pre id='715FF3EFAD'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:78897
          Portrait of R. Shawn Martin -- health coverage from STAT
          R. Shawn Martin, the CEO of the American Academy of Family Physicians Courtesy American Academy of Family Physicians

          In ten years, the United States could be short as many as 48,000 primary care doctors. The specialty is underpaid, to a point that doctors are lobbying Medicare to pay it extra. Even medical residents who chose the specialty are leaving primary care; some 45% of residents who planned to be generalists changed their mind during their residencies.

          But R. Shawn Martin, the CEO of the American Academy of Family Physicians, the specialty trade group, isn’t worried.

          advertisement

          “I’ve been around this and at this a long time and family medicine and primary care’s obituary has been written many times in my 25-plus years of doing this work,” he said with a laugh. “This isn’t the first time that primary care has been dying or fading away.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          ALS groups 'won't be played again' by the FDA, drug sponsors
          ALS groups 'won't be played again' by the FDA, drug sponsors

          MattScozzariholdshisgirlfriendSabrinaParker'shandduringafriendshipceremonyinJacksonville,N.C.,inNove

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Trial using CRISPR to edit HIV out of cells disappoints

          AdobeBALTIMORE—AnambitiousefforttocureHIVwithCRISPRgenomeeditingfellshortinanearlyclinicaltrial,inve